Table of Contents
Advances in Pharmaceutics
Volume 2014, Article ID 304392, 6 pages
http://dx.doi.org/10.1155/2014/304392
Research Article

Pharmacodynamics and Pharmacokinetics Evaluation of Ranitidine Microemulsion on Experimental Animals

1Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences & Research, BRB Sarani, Bidhannagar, Durgapur, West Bengal 713212, India
2Department of Industrial Pharmacy, Acharya & BM Reddy College of Pharmacy, Soldevanahalli, Bangalore, Karnataka 560090, India

Received 18 July 2014; Revised 29 August 2014; Accepted 2 October 2014; Published 20 October 2014

Academic Editor: Maria Cristina Bonferoni

Copyright © 2014 Sajal Kumar Jha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Karthikeyan and K. Gobianand, “Antiulcer activity of ethanol leaf extract of Cassia fistula,” Pharmaceutical Biology, vol. 48, no. 8, pp. 869–877, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Ramchandran, G. Poovi, and M. D. Dhanaraju, “Evaluation of gastric and duodenal antiulcer activity of famotidine formulation in experimental animals,” Journal of Pharmacological and Toxicological, vol. 6, no. 2, pp. 189–195, 2011. View at Google Scholar
  3. C. Zhang, L. Wang, X. Guan et al., “Rapid determination of ranitidine in human plasma by liquid chromatography-tandem mass spectrometry and its application to a clinical pharmacokinetic study,” Chemical Research in Chinese Universities, vol. 26, no. 6, pp. 910–914, 2010. View at Google Scholar · View at Scopus
  4. D. Hollander, A. Tarnawski, W. J. Krause, and H. Gergely, “Protective effect of sucralfate against alcohol-induced gastric mucosal injury in the rat: macroscopic, histologic, ultrastructural , and functional time sequence analysis,” Gastroenterology, vol. 88, no. 1, pp. 366–374, 1985. View at Publisher · View at Google Scholar
  5. S. G. Patel, S. J. Rajput, A. Groshev, and V. B. Sutariya, “Preparation and characterization of microemulsion of cilostazol for enhancement of oral bioavailability,” Current Drug Delivery, vol. 11, no. 3, pp. 531–540, 2014. View at Google Scholar
  6. Q. Cai, H. Sun, Y. Pen et al., “A potent and orally active antagonist of multiple inhibitor of apoptosis proteins (IAPs) (SM-406/AT-406) in clinical development for cancer treatment,” Journal of Medicinal Chemistry, vol. 54, no. 8, pp. 2714–2726, 2011. View at Publisher · View at Google Scholar
  7. R. ParveenShaika, S. B. Puttagunta, C. B. Kothapalli, B. Z. S. Awen, and B. R. Challa, “A validated LC-MS/MS method for the determination of tolterodine and its metabolite in rat plasma and application to pharmacokinetic study,” Journal of Pharmaceutical Analysis, vol. 3, no. 6, pp. 489–499, 2013. View at Google Scholar
  8. R. G. Thorne and W. H. Frey II, “Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations,” Clinical Pharmacokinetics, vol. 40, no. 12, pp. 907–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Born, T. Lange, and W. Kern, “Sniffing neuropeptides: a transnasal approach to the human brain,” Nature Neuroscience, vol. 5, pp. 514–516, 2002. View at Google Scholar
  10. L. Illum, “Nasal drug delivery: new developments and strategies,” Drug Discovery Today, vol. 7, no. 23, pp. 1184–1189, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Patel, R. B. Patel, J. R. Parikh, A. B. Solanki, and B. G. Patel, “Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole,” AAPS PharmSciTech, vol. 10, no. 3, pp. 917–923, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. R. Patel, R. B. Patel, and J. R. Parikh, “Investigation of efficiency of isopropyl myristate-based oil in water microemulsions for topical delivery of fluconazole,” International Journal of Biomedical and Pharmaceutical Sciences, vol. 3, pp. 60–68, 2009. View at Google Scholar
  13. M. R. Patel, R. B. Patel, J. R. Parikh, A. B. Solanki, and B. G. Patel, “Investigating effect of microemulsion components: In vitro permeation of ketoconazole,” Pharmaceutical Development and Technology, vol. 16, no. 3, pp. 250–258, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Sener, K. Paskaloglu, and G. Ayanoglu-Dülger, “Protective effect of increasing doses of famotidine, omeprazole, lansoprazole, and melatonin against ethanol-induced gastric damage in rats,” Indian Journal of Pharmacology, vol. 36, no. 3, pp. 171–174, 2004. View at Google Scholar · View at Scopus
  15. Y.-M. Yin, F.-D. Cui, C.-F. Mu et al., “Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation,” Journal of Controlled Release, vol. 140, no. 2, pp. 86–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Sharma, K. Wilson, C. F. van der Walle, N. Sattar, J. R. Petrie, and M. N. V. Ravi Kumar, “Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 2, pp. 159–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Hu, H. Wu, F. Niu, C. Yan, X. Yang, and Y. Jia, “Design of fenofibrate microemulsion for improved bioavailability,” International Journal of Pharmaceutics, vol. 420, no. 2, pp. 251–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Araya, M. Tomita, and M. Hayashi, “The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds,” International Journal of Pharmaceutics, vol. 305, no. 1-2, pp. 61–74, 2005. View at Publisher · View at Google Scholar · View at Scopus